Mohamed Elshenawy, PhD

Senior Scientist at EvolveImmune Therapeutics

Speaker

Mohamed M. Elshenawy, PhD, is a Principal Scientist at EvolveImmune Therapeutics with more than 10 years of experience in protein and antibody engineering, therapeutic biologics development, and analytical sciences. At EvolveImmune, he drives efforts in the design and development of next-generation multispecific antibody therapeutics and new technologies for the EVOLVE T-cell engager platform. Prior to EvolveImmune, Mohamed was a Staff Scientist at Quantum-Si, where he focused on the engineering, development, and characterization of antibodies and protein binders for next-generation single-molecule protein sequencing technology.